Discover the most recent news about our Company.
El passat 24 de novembre va tenir lloc a Madrid el seminari Biotec “2021 l’any de la biotecnologia” en el
On 24 November, the Biotec seminar “2021 the year of biotechnology” took place in Madrid as part of the second
Patients with type 2 diabetes mellitus (T2DM) and atherogenic dyslipidemia (AD) are at higher risk of developing cardiovascular diseases (CVDs),
Last 23rd and 24th November, our Quality Manager Sara Samino, participated in the first Futurecamp Open Future, eHealth & Wellbeing
El passat 23 i 24 de novembre, la nostra Quality Manager Sara Samino, va participar al primer Futurecamp Open Future,
We aimed to assess the potential relationship between dietary patterns (i.e., Mediterranean diet and healthy eating) and the advanced lipoprotein
From 12 to 15 November took place the “The liver Meeting” organised by the American Association for the Study of
El Barça Innovation Hub (BIHUB) va néixer fa 4 anys creat pel club blaugrana per desenvolupar al nivell més alt
The Barça Innovation Hub (BIHUB) was created four years ago by the FC Barcelona to develop technological advances applied to sport
Aims: The impact of glycemic optimization on lipoprotein subfraction parameters in apparently normolipidemic subjects with new-onset type 1 diabetes mellitus (T1D)
Introducción y objetivos El fenotipado avanzado de lipoproteínas es mejor predictor del riesgo aterosclerótico que el colesterol. El perfil de
Introduction and objectives: Advanced lipoprotein phenotyping is a better predictor of atherosclerotic cardiovascular risk than cholesterol concentration alone. Lipoprotein profiling in
